https://ukneqasli.ds-test.co.uk/programme/cd34-stem-cell-enumeration-programme-accredited/2026-08-21T15:14:01+00:00https://ukneqasli.ds-test.co.uk/programme/immune-monitoring-accredited/2026-08-21T15:13:55+00:00https://ukneqasli.ds-test.co.uk/programme/leukaemia-immunophenotyping-accredited/2026-08-21T15:16:29+00:00https://ukneqasli.ds-test.co.uk/programme/leukaemia-diagnostic-interpretation-accredited/2026-08-21T15:19:43+00:00https://ukneqasli.ds-test.co.uk/programme/low-level-leucocyte-enumeration-accredited/2026-08-21T15:21:25+00:00https://ukneqasli.ds-test.co.uk/programme/measurable-residual-disease-for-all-by-flow-cytometry-accredited/2026-08-21T15:25:00+00:00https://ukneqasli.ds-test.co.uk/programme/paroxysmal-nocturnal-haemoglobinuria-accredited/2026-08-21T15:26:59+00:00https://ukneqasli.ds-test.co.uk/programme/cd19-car-t-cell-monitoring-by-flow-cytometry-programme-pilot-not-accredited/2026-08-21T15:31:47+00:00https://ukneqasli.ds-test.co.uk/programme/cerebrospinal-fluid-csf-immunophenotyping-pilot-not-accredited/2026-08-21T15:47:01+00:00https://ukneqasli.ds-test.co.uk/programme/haematological-malignancy-bone-marrow-aspirate-assessment-pilot-not-accredited/2026-08-21T15:46:56+00:00https://ukneqasli.ds-test.co.uk/programme/measurable-residual-disease-for-aml-by-flow-cytometry-pilot-not-accredited/2026-08-21T15:43:24+00:00https://ukneqasli.ds-test.co.uk/programme/measurable-residual-disease-for-cll-by-flow-cytometry-pilot-not-accredited/2026-08-21T15:44:52+00:00https://ukneqasli.ds-test.co.uk/programme/measurable-residual-disease-for-plasma-cell-myeloma-by-flow-cytometry-pilot-not-accredited/2026-08-21T15:46:15+00:00https://ukneqasli.ds-test.co.uk/programme/bcrabl1-and-aml-translocation-identification-accredited/2026-08-24T16:32:40+00:00https://ukneqasli.ds-test.co.uk/programme/bcrabl1-kinase-domain-variant-mutation-status-accredited/2026-08-24T16:52:58+00:00https://ukneqasli.ds-test.co.uk/programme/bcrabl1-major-quantification-accredited/2026-08-24T16:53:33+00:00https://ukneqasli.ds-test.co.uk/programme/bcrabl1-minor-quantification-accredited/2026-08-24T17:01:25+00:00https://ukneqasli.ds-test.co.uk/programme/braf-p-val600glu-v600e-mutation-status-for-hairy-cell-leukaemia-accredited/2026-08-25T13:24:00+00:00https://ukneqasli.ds-test.co.uk/programme/flt3-mutation-status-accredited/2026-08-25T13:37:33+00:00https://ukneqasli.ds-test.co.uk/programme/ig-tcr-clonality-status-accredited/2026-08-25T13:44:32+00:00https://ukneqasli.ds-test.co.uk/programme/kit-p-asp816val-d816v-mutation-status-for-mast-cell-disease-accredited/2026-08-25T13:46:29+00:00https://ukneqasli.ds-test.co.uk/programme/lymphoplasmacytic-lymphoma-waldenstrom-macroglobulinaemia-accredited/2026-08-25T14:05:13+00:00https://ukneqasli.ds-test.co.uk/programme/myeloproliferative-neoplasms-diagnostic-testing/2026-08-25T13:51:19+00:00https://ukneqasli.ds-test.co.uk/programme/npm1-mutation-status-accredited/2026-08-25T13:54:19+00:00https://ukneqasli.ds-test.co.uk/programme/paediatric-acute-leukaemia-translocations-accredited/2026-08-25T13:55:46+00:00https://ukneqasli.ds-test.co.uk/programme/post-stem-cell-transplant-chimerism-monitoring-accredited/2026-08-25T13:57:58+00:00https://ukneqasli.ds-test.co.uk/programme/lymphoid-gene-panels-pilot-not-accredited/2026-08-25T13:59:38+00:00https://ukneqasli.ds-test.co.uk/programme/measurable-residual-disease-for-aml-by-molecular-methods-pilot-not-accredited/2026-08-25T14:01:26+00:00https://ukneqasli.ds-test.co.uk/programme/measurable-residual-disease-for-lymphoid-neoplasms-by-molecular-methods-pilot-not-accredited/2026-08-25T14:02:35+00:00https://ukneqasli.ds-test.co.uk/programme/myeloid-gene-panels-pilot-not-accredited/2026-08-25T14:04:30+00:00https://ukneqasli.ds-test.co.uk/programme/diffuse-large-b-cell-lymphoma-liquid-biopsy-study/2026-08-25T14:14:01+00:00